Rallybio Corporation
RLYB
$0.626
$0.0325.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 457.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 457.89% | |||
| Cost of Revenue | -89.21% | -22.48% | |||
| Gross Profit | 92.64% | 24.96% | |||
| SG&A Expenses | 0.91% | -2.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.92% | -15.15% | |||
| Operating Income | -4.00% | 16.70% | |||
| Income Before Tax | -2.80% | 14.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.80% | 14.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.80% | 14.53% | |||
| EBIT | -4.00% | 16.70% | |||
| EBITDA | -4.03% | 16.72% | |||
| EPS Basic | -2.66% | 14.76% | |||
| Normalized Basic EPS | -2.58% | 14.75% | |||
| EPS Diluted | -2.66% | 14.76% | |||
| Normalized Diluted EPS | -2.58% | 14.75% | |||
| Average Basic Shares Outstanding | 0.15% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||